Arrowhead Pharmaceuticals (ARWR) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ARWR Arrowhead Pharmaceuticals

Watchlist

19.450
-0.050-0.26%

Close Dec 20 16:00 ET

19.690
+0.240+1.23%

Post 20:05 ET

2.42BMarket Cap-3.89P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

H.C. Wainwright Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $80
Moomoo NewsDec 20 14:31 ET · Ratings
Arrowhead Pharmaceuticals Price Target Maintained With a $80.00/Share by HC Wainwright & Co.
Dow JonesDec 20 11:12 ET · Ratings
Arrowhead Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BusinesswireDec 19 16:59 ET
Express News | Arrowhead Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ReutersDec 19 16:59 ET
Leadership Transition at Arrowhead Pharmaceuticals' Board
TipRanksDec 18 06:34 ET
In the Wake of Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) Latest US$112m Market Cap Drop, Institutional Owners May Be Forced to Take Severe Actions
Simply Wall StDec 17 12:16 ET

Comments

Andrew Whiteside

Nov 22 09:29

$Arrowhead Pharmaceuticals (ARWR.US)$ $50

stockhub

Apr 7 11:23

Hope price action is consistent with result

Plozasiran reduced triglycerides and APOC3 up to a mean maximum of 86% and 90% respectively in patients with severe hypertriglyceridemia
$Arrowhead Pharmaceuticals (ARWR.US)$

Mooers' Insights

Tonyco

Apr 6 22:01

$Arrowhead Pharmaceuticals (ARWR.US)$
Insiderd selling shares and financials dont look good. Im guessing they dont have anything in the pipeline?

Moomoo AI

Mar 8 05:54

The company's poor performance and the CEO's high pay, despite falling earnings and shareholder value, may upset shareholders. The upcoming AGM on March 14th is a chance for shareholders to hold the board and management accountable.